{"id":49317,"date":"2022-10-07T10:01:36","date_gmt":"2022-10-07T08:01:36","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/waters-marks-25-years-in-ireland-with-e6-million-clinical-diagnostics-rd-center-expansion-in-wexford\/"},"modified":"2022-10-07T10:01:36","modified_gmt":"2022-10-07T08:01:36","slug":"waters-marks-25-years-in-ireland-with-e6-million-clinical-diagnostics-rd-center-expansion-in-wexford","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/waters-marks-25-years-in-ireland-with-e6-million-clinical-diagnostics-rd-center-expansion-in-wexford\/","title":{"rendered":"Waters Marks 25 Years in Ireland with \u20ac6 Million Clinical Diagnostics R&amp;D Center Expansion in Wexford"},"content":{"rendered":"<div>\n<p>\n<b>News Summary:<\/b>\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20221007005094\/en\/1595142\/5\/Wexford_14.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20221007005094\/en\/1595142\/21\/Wexford_14.jpg\"><\/a><br \/><a href=\"https:\/\/mms.businesswire.com\/media\/20221007005094\/en\/1335697\/5\/WAT_logo_Black.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20221007005094\/en\/1335697\/21\/WAT_logo_Black.jpg\"><\/a><\/p>\n<ul class=\"bwlistdisc\">\n<li>\nWaters Corporation commits multi-year investment with support from IDA Ireland to help accelerate life sciences industry growth in the South-East.\n<\/li>\n<li>\nResearch and Development center expansion will create new scientific jobs focused on solutions for broader clinical diagnostic applications.\n<\/li>\n<li>\nWaters celebrates 25<sup>th<\/sup> anniversary in Ireland at Wexford facility with T\u00e1naiste and Minister for Enterprise, Trade and Employment, Leo Varadkar TD.\n<\/li>\n<\/ul>\n<p>WEXFORD, Ireland&#8211;(BUSINESS WIRE)&#8211;<a href=\"https:\/\/twitter.com\/hashtag\/ClinicalDx?src=hash\" target=\"_blank\" rel=\"noopener\">#ClinicalDx<\/a>&#8211;Waters Corporation (NYSE: WAT) today announced a combined investment of up to \u20ac6 million with support from IDA Ireland to expand its operations in Drinagh, Wexford to fund research and development (R&amp;D) of new clinical diagnostics products. The operational expansion at the Wexford facility will create new scientific jobs through 2024.\n<\/p>\n<p>\nWaters\u2019 Wexford facility is the company\u2019s primary site for manufacturing and delivery of its portfolio of in-vitro diagnostic (IVD) systems, reagent kits, and software used by thousands of hospitals and laboratories worldwide for applications that include health screening for millions of newborn babies.\n<\/p>\n<p>\nWaters is formally making the announcement at its Wexford campus this afternoon with government and business leaders to mark 25 years of doing business in Ireland.\n<\/p>\n<p>\n\u201cThis is a fantastic investment in Wexford by Waters Corporation which will bolster the thriving life sciences cluster in the region,\u201d said T\u00e1naiste and Minister for Enterprise, Trade and Employment, Leo Varadkar TD. \u201cThe Government is committed to job creation in all corners of our country, and we are creating the right environment for investment in the South-East with improved road, port and broadband infrastructure as well as the new Technological University. Ireland has become recognized globally for our workforce talent, including the scientific research which is making big advances in medical technologies and diagnostics software.\n<\/p>\n<p>\n\u201cThis \u20ac6 million R&amp;D investment will further improve Waters\u2019 mass spectrometry offerings for clinical diagnostics,\u201d he continued. \u201cThese developments have real-life impacts, improving the outcome for many conditions, including early disease detection. Waters Corporation is a global leader and a significant employer in Wexford where it has operated for 25 years. I wish the team every continued success.\u201d\n<\/p>\n<p>\nThe multi-year investment is part of Waters\u2019 strategic mission announced in 2021 to evaluate the potential of its mass spectrometry technologies for broader diagnostic solutions in areas of early disease detection such as cancer screening.\n<\/p>\n<p>\n\u201cThis expansion in Wexford is a tremendous step forward for the Waters Clinical Diagnostics business and we\u2019re delighted with the support from IDA Ireland who are enabling growth of the life sciences industry in the South-East,\u201d said Liam Hore, Waters Corporation, Wexford General Manager. \u201cWith the creation of new jobs and opening of new lab space in Wexford, our R&amp;D Center will make it possible for Waters\u2019 mass spectrometry technology to play an even greater role in clinical diagnostics, raising the standard of accuracy in the diagnosis of many clinical conditions where the performance of existing tests is lacking.\u201d\n<\/p>\n<p>\n\u201cThis announcement by Waters to expand its site in Wexford is very welcome news,\u201d said Martin Shanahan, CEO of IDA Ireland. \u201cThe investment will significantly enhance the capability of the facility. IDA Ireland remains committed to winning jobs and investment for regional locations. I wish Waters every success with this project.\u201d\n<\/p>\n<p>\nT\u00e1naiste, Wexford Mayor Maura Bell, IDA Ireland Executive Director Mary Buckley, and Waters Senior Vice President of Global Operations Chris Ross gathered with employees and leaders from national and local government and industry at an event held at Waters\u2019 Wexford site to formally announce the investment in partnership with IDA Ireland (<i>event photos available through PR contacts below<\/i>).\n<\/p>\n<p>\nThe Wexford facility is one of Waters\u2019 key global sites, incorporating a variety of manufacturing, warehouse, laboratory and office spaces. Waters has been a significant employer in Wexford since its establishment in 1997, with over 400 employed at the site today. It is a global production and distribution center for a range of consumables (\u2018columns\u2019) for the company\u2019s High Performance Liquid Chromatography (HPLC) and Ultra Performance Liquid Chromatography (UPLC) instruments. Waters employees at the Wexford facility also assemble and test mass spectrometry instruments and replicate instrument software.\n<\/p>\n<p>\n<b>Additional Resources<\/b>\n<\/p>\n<ul class=\"bwlistdisc\">\n<li>\nVisit the Waters Careers page for <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Finternationalcareers-waters.icims.com%2Fjobs%2Fsearch%3Fss%3D1%26searchLocation%3D13267-14631-Wexford&amp;esheet=52939545&amp;newsitemid=20221007005094&amp;lan=en-US&amp;anchor=Waters+job+openings+in+Wexford&amp;index=1&amp;md5=ba73da4d3ba5d12ffe5bd81432de8a25\" rel=\"nofollow noopener\" shape=\"rect\">Waters job openings in Wexford<\/a>\n<\/li>\n<li>\nTake a <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fvideos.waters.com%2Fdetail%2Fvideos%2Fabout-waters%2Fvideo%2F6305836830112&amp;esheet=52939545&amp;newsitemid=20221007005094&amp;lan=en-US&amp;anchor=video+tour+of+our+Waters+facility+in+Wexford&amp;index=2&amp;md5=5607417b474087c0eb7c8c2a9a7f8e8c\" rel=\"nofollow noopener\" shape=\"rect\">video tour of our Waters facility in Wexford<\/a>\n<\/li>\n<li>\nLearn more about the <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.waters.com%2Fnextgen%2Fus%2Fen%2Fapplications%2Fclinical-diagnostics.html&amp;esheet=52939545&amp;newsitemid=20221007005094&amp;lan=en-US&amp;anchor=Waters+Clinical+Diagnostics&amp;index=3&amp;md5=a072fd989d342997ef55d05b29ff445b\" rel=\"nofollow noopener\" shape=\"rect\">Waters Clinical Diagnostics<\/a> portfolio\n<\/li>\n<li>\nFollow and connect with Waters via <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fwaters%2F&amp;esheet=52939545&amp;newsitemid=20221007005094&amp;lan=en-US&amp;anchor=LinkedIn&amp;index=4&amp;md5=017c36da71b1bde941c80e710ff504ad\" rel=\"nofollow noopener\" shape=\"rect\">LinkedIn<\/a>, <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Ftwitter.com%2FWatersCorp&amp;esheet=52939545&amp;newsitemid=20221007005094&amp;lan=en-US&amp;anchor=Twitter&amp;index=5&amp;md5=47228867ce37922216d321df4c2833c4\" rel=\"nofollow noopener\" shape=\"rect\">Twitter<\/a>, and <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.facebook.com%2FWaters&amp;esheet=52939545&amp;newsitemid=20221007005094&amp;lan=en-US&amp;anchor=Facebook&amp;index=6&amp;md5=c91099ad58af570267c4edc3f06ffd0f\" rel=\"nofollow noopener\" shape=\"rect\">Facebook<\/a>\n<\/li>\n<\/ul>\n<p>\n<b>About Waters Corporation (<\/b><a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.waters.com%2F&amp;esheet=52939545&amp;newsitemid=20221007005094&amp;lan=en-US&amp;anchor=www.waters.com&amp;index=7&amp;md5=8db3aa1e8373cc31bf0d8430884210bc\" rel=\"nofollow noopener\" shape=\"rect\"><b>www.waters.com<\/b><\/a><b>)<\/b>\n<\/p>\n<p>\n<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.waters.com%2F&amp;esheet=52939545&amp;newsitemid=20221007005094&amp;lan=en-US&amp;anchor=Waters+Corporation&amp;index=8&amp;md5=af75c2a4b498602f00c899ee01ad9957\" rel=\"nofollow noopener\" shape=\"rect\">Waters Corporation<\/a> (NYSE:WAT), a global leader in analytical instruments and software, has pioneered innovations in chromatography, mass spectrometry, and thermal analysis serving the life, materials, and food sciences for over 60 years. With more than 7,800 employees worldwide, Waters operates directly in 35 countries, including 14 manufacturing facilities, and with products available in more than 100 countries.\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nPress:\n<\/p>\n<p>\nKevin Kempskie<br \/>\n<br \/>Senior Director, Public Relations<br \/>\n<br \/>Waters Corporation<br \/>\n<br \/><a target=\"_blank\" href=\"&#x6d;&#x61;&#105;lt&#x6f;&#x3a;&#107;&#101;v&#x69;&#x6e;&#95;&#107;e&#x6d;&#x70;&#x73;&#107;ie&#x40;&#x77;&#97;&#116;e&#x72;&#x73;&#46;&#99;o&#x6d;\" rel=\"nofollow noopener\" shape=\"rect\">kevin_kempskie&#64;waters&#46;co&#109;<\/a>\n<\/p>\n<p>\nEllen Lynch<br \/>\n<br \/>Press &amp; PR Manager<br \/>\n<br \/>IDA Ireland<br \/>\n<br \/>087 4112084<br \/>\n<br \/><a target=\"_blank\" href=\"ma&#105;&#108;&#116;&#x6f;&#x3a;&#x65;&#x6c;le&#110;&#46;&#108;&#x79;&#x6e;&#x63;&#x68;&#64;i&#100;&#97;&#46;&#x69;&#x65;\" rel=\"nofollow noopener\" shape=\"rect\">&#x65;&#x6c;&#108;&#101;n&#x2e;&#x6c;&#x79;&#110;ch&#x40;&#x69;&#100;&#97;&#46;&#x69;&#x65;<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>News Summary: Waters Corporation commits multi-year investment with support from IDA Ireland to help accelerate life sciences industry growth in the South-East. Research and Development center expansion will create new scientific jobs focused on solutions for broader clinical diagnostic applications. Waters celebrates 25th anniversary in Ireland at Wexford facility with T\u00e1naiste and Minister for Enterprise, &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/waters-marks-25-years-in-ireland-with-e6-million-clinical-diagnostics-rd-center-expansion-in-wexford\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-49317","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Waters Marks 25 Years in Ireland with \u20ac6 Million Clinical Diagnostics R&amp;D Center Expansion in Wexford - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/waters-marks-25-years-in-ireland-with-e6-million-clinical-diagnostics-rd-center-expansion-in-wexford\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Waters Marks 25 Years in Ireland with \u20ac6 Million Clinical Diagnostics R&amp;D Center Expansion in Wexford - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"News Summary: Waters Corporation commits multi-year investment with support from IDA Ireland to help accelerate life sciences industry growth in the South-East. Research and Development center expansion will create new scientific jobs focused on solutions for broader clinical diagnostic applications. Waters celebrates 25th anniversary in Ireland at Wexford facility with T\u00e1naiste and Minister for Enterprise, ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/waters-marks-25-years-in-ireland-with-e6-million-clinical-diagnostics-rd-center-expansion-in-wexford\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-10-07T08:01:36+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20221007005094\/en\/1595142\/21\/Wexford_14.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/waters-marks-25-years-in-ireland-with-e6-million-clinical-diagnostics-rd-center-expansion-in-wexford\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/waters-marks-25-years-in-ireland-with-e6-million-clinical-diagnostics-rd-center-expansion-in-wexford\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Waters Marks 25 Years in Ireland with \u20ac6 Million Clinical Diagnostics R&amp;D Center Expansion in Wexford\",\"datePublished\":\"2022-10-07T08:01:36+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/waters-marks-25-years-in-ireland-with-e6-million-clinical-diagnostics-rd-center-expansion-in-wexford\\\/\"},\"wordCount\":816,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/waters-marks-25-years-in-ireland-with-e6-million-clinical-diagnostics-rd-center-expansion-in-wexford\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221007005094\\\/en\\\/1595142\\\/21\\\/Wexford_14.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/waters-marks-25-years-in-ireland-with-e6-million-clinical-diagnostics-rd-center-expansion-in-wexford\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/waters-marks-25-years-in-ireland-with-e6-million-clinical-diagnostics-rd-center-expansion-in-wexford\\\/\",\"name\":\"Waters Marks 25 Years in Ireland with \u20ac6 Million Clinical Diagnostics R&amp;D Center Expansion in Wexford - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/waters-marks-25-years-in-ireland-with-e6-million-clinical-diagnostics-rd-center-expansion-in-wexford\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/waters-marks-25-years-in-ireland-with-e6-million-clinical-diagnostics-rd-center-expansion-in-wexford\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221007005094\\\/en\\\/1595142\\\/21\\\/Wexford_14.jpg\",\"datePublished\":\"2022-10-07T08:01:36+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/waters-marks-25-years-in-ireland-with-e6-million-clinical-diagnostics-rd-center-expansion-in-wexford\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/waters-marks-25-years-in-ireland-with-e6-million-clinical-diagnostics-rd-center-expansion-in-wexford\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/waters-marks-25-years-in-ireland-with-e6-million-clinical-diagnostics-rd-center-expansion-in-wexford\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221007005094\\\/en\\\/1595142\\\/21\\\/Wexford_14.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221007005094\\\/en\\\/1595142\\\/21\\\/Wexford_14.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/waters-marks-25-years-in-ireland-with-e6-million-clinical-diagnostics-rd-center-expansion-in-wexford\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Waters Marks 25 Years in Ireland with \u20ac6 Million Clinical Diagnostics R&amp;D Center Expansion in Wexford\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Waters Marks 25 Years in Ireland with \u20ac6 Million Clinical Diagnostics R&amp;D Center Expansion in Wexford - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/waters-marks-25-years-in-ireland-with-e6-million-clinical-diagnostics-rd-center-expansion-in-wexford\/","og_locale":"en_US","og_type":"article","og_title":"Waters Marks 25 Years in Ireland with \u20ac6 Million Clinical Diagnostics R&amp;D Center Expansion in Wexford - Pharma Trend","og_description":"News Summary: Waters Corporation commits multi-year investment with support from IDA Ireland to help accelerate life sciences industry growth in the South-East. Research and Development center expansion will create new scientific jobs focused on solutions for broader clinical diagnostic applications. Waters celebrates 25th anniversary in Ireland at Wexford facility with T\u00e1naiste and Minister for Enterprise, ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/waters-marks-25-years-in-ireland-with-e6-million-clinical-diagnostics-rd-center-expansion-in-wexford\/","og_site_name":"Pharma Trend","article_published_time":"2022-10-07T08:01:36+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20221007005094\/en\/1595142\/21\/Wexford_14.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/waters-marks-25-years-in-ireland-with-e6-million-clinical-diagnostics-rd-center-expansion-in-wexford\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/waters-marks-25-years-in-ireland-with-e6-million-clinical-diagnostics-rd-center-expansion-in-wexford\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Waters Marks 25 Years in Ireland with \u20ac6 Million Clinical Diagnostics R&amp;D Center Expansion in Wexford","datePublished":"2022-10-07T08:01:36+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/waters-marks-25-years-in-ireland-with-e6-million-clinical-diagnostics-rd-center-expansion-in-wexford\/"},"wordCount":816,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/waters-marks-25-years-in-ireland-with-e6-million-clinical-diagnostics-rd-center-expansion-in-wexford\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221007005094\/en\/1595142\/21\/Wexford_14.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/waters-marks-25-years-in-ireland-with-e6-million-clinical-diagnostics-rd-center-expansion-in-wexford\/","url":"https:\/\/pharma-trend.com\/en\/waters-marks-25-years-in-ireland-with-e6-million-clinical-diagnostics-rd-center-expansion-in-wexford\/","name":"Waters Marks 25 Years in Ireland with \u20ac6 Million Clinical Diagnostics R&amp;D Center Expansion in Wexford - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/waters-marks-25-years-in-ireland-with-e6-million-clinical-diagnostics-rd-center-expansion-in-wexford\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/waters-marks-25-years-in-ireland-with-e6-million-clinical-diagnostics-rd-center-expansion-in-wexford\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221007005094\/en\/1595142\/21\/Wexford_14.jpg","datePublished":"2022-10-07T08:01:36+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/waters-marks-25-years-in-ireland-with-e6-million-clinical-diagnostics-rd-center-expansion-in-wexford\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/waters-marks-25-years-in-ireland-with-e6-million-clinical-diagnostics-rd-center-expansion-in-wexford\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/waters-marks-25-years-in-ireland-with-e6-million-clinical-diagnostics-rd-center-expansion-in-wexford\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20221007005094\/en\/1595142\/21\/Wexford_14.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20221007005094\/en\/1595142\/21\/Wexford_14.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/waters-marks-25-years-in-ireland-with-e6-million-clinical-diagnostics-rd-center-expansion-in-wexford\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Waters Marks 25 Years in Ireland with \u20ac6 Million Clinical Diagnostics R&amp;D Center Expansion in Wexford"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/49317","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=49317"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/49317\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=49317"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=49317"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=49317"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}